Insulin resistance in nondiabetic patients with acute myocardial infarction

Cardiovascular Revascularization Medicine

Volumn 7, Issue 2, 2006, Pages 54-60

  Nishio, Kazuaki ^a   Shigemitsu, Meiei ^a   Kusuyama, Taro ^a   Fukui, Tomoyasu ^a   Kawamura, Kitaro ^a   Itoh, Seiji ^a   Konno, Noburu ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; eNOS; Insulin resistance; Leptin; Stress hormones

Indexed keywords

ADIPONECTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCAGON; HORMONE; HYDROCORTISONE; INTERLEUKIN 6; LEPTIN; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOSPITAL DISCHARGE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MALE; METAL STENT; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RESTENOSIS;

AGED; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STENTS;

EID: 33744529009     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2005.12.004     Document Type: Article

References (40)

1. Oswald G., Smith C., Betteridge J., and Yudkin J. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. BMJ 293 (1986) 917-922
2. O'Sullivan J., Conroy R., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes care 14 (1991) 758-760
3. Bellodi G., Manicardi V., Malvasi V., Veneri L., Bernini G., Bossini P., Distefano S., Magnani L., and Rossi G. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64 (1989) 885-888
4. Fava S., Aquilina O., Azzopardi J., Muscat H., and Fenech F. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabetic Med 13 (1996) 80-83
5. Stubbs P., Laycock J., Alaghband-Zadeh J., Carter G., and Noble M. Circulating stress hormone and insulin concentrations in acute coronary syndrome: identification of insulin resistance on admission. Clin Sci 96 (1999) 589-595
6. Despres J., Lamarche B., Mauriege P., Cantin B., Dagenais G., Moorjani S., and Lupien P. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
7. Reaven G. Banting Lecture 188: Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
8. DeFronzo R., and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
9. Piatti P., Mario C., Monti L., Fragasso G., Sgura F., Caumo A., Setola E., Lucotti P., Galluccio E., Ronchi C., Origgi A., Zavaroni I., Margonato A., and Colombo A. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 108 (2003) 2074-2081
10. Hedblad B., Nilsson P., Engström G., Berglund G., and Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 19 (2002) 470-475
11. Cohn J., Levine T., Olivari M., Garberg V., Luna D., Francis G., Simon A., and Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med 311 (1984) 819-823
12. Jewitt D., Mercer C., Reid D., Valori C., Thomas M., and Shillingford J. Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmia and heart-failure in patients with acute myocardial infarction. Lancet i (1969) 635-641
13. Klein D., Anderson Friedman L., Harlan W., Barton B., Schreiber G., Cohen R., Harlan L., and Morrison J. Obesity and the development of insulin resistance and impaired fasting glucose in Black and White adolescent girls. Diabetes Care 27 (2004) 378-383
14. Tenerz A., Norhammar A., Silveira A., Hamsten A., Nilsson G., Rydén L., and Malmberg K. Diabetes, insulin resistance, and metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 26 (2003) 2770-2776
15. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., and Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28 (1985) 412-419
16. Friedewald W., Levy R., and Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1978) 499-502
17. Hotamisligil G., Shargill N., and Spiegelman B. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
18. Kern P., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
19. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
20. Alberti K., Zimmet P., and for the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus-provisional report of a WHO consultation. Diabetic Med 15 (1998) 539-553
21. Anon. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000) 1502-1513
22. Anon. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
23. Opie L. Glucose and the metabolism of ischemic myocardial infarction. Lancet 345 (1995) 1520-1521
24. Christenson N., and Videbak J. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest 54 (1974) 278-286
25. Stubbs P., Laycock J., Alaghband-Zadeh J., Carter G., and Noble M. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin Sci 96 (1999) 589-595
26. Pavlou H., Kliridis P., Panagiotopoulos A., Goritsas C., and Vassilakos P. Euthyroid sick syndrome in acute ischemic syndromes. Angiology 53 (2002) 699-707
27. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 88 (1990) 631-637
28. Willerson J., Hutcheson D., Leshin S., Faloona G., and Unger R. Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med 57 (1974) 747-753
29. Wallace A., McMahon A., Packard C., Kelly A., Shepherd J., Gaw A., and Sattar N. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104 (2001) 3052-3056
30. Schäfer K., Halle M., Goeschen C., Dellas C., Pynn M., Loskutoff D., and Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24 (2004) 112-117
31. Kolaczynski J., Nyce M., Considine R., Boden G., Nolan J., Henry R., Mudaliar S., Olefsky J., and Caro J. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45 (1996) 699-701
32. Wabitsch M., Jensen P., Blum W., Christoffersen C., Englaro P., Heinze E., Rascher W., Teller W., Tornqvist H., and Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45 (1996) 1435-1438
33. Bradley S., Kingwell B., and McConell G. Nitric oxide synthase inhibition reduced leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48 (1999) 1815-1821
34. Shiuchi T., Nakagami H., Iwai M., Takeda Y., Cui T., Chen R., Minokoshi Y., and Horiuchi M. Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle. Endocrinology 142 (2001) 608-612
35. Lusis A. Atherosclerosis. Nature 407 (2000) 233-241
36. Piatti P., Monti L., Zavaroni I., Valsecchi G., VanPhan C., Costa S., Conti M., Sandoli E., Solerte B., Pozza G., Pontiroli A., and Reaven G. Alteration in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with Type 2 diabetes. J Clin Endocrinol Metab 85 (2000) 2416-2420
37. Zavaroni I., Piatti P., Monti L., Gasparini P., Barilli L., Massironi P., Ardigo D., Valsecchi G., Delsignore R., and Reaven G. Plasma nitric oxide concentrations are elevated in insulin-resistance healthy subjects. Metabolism 49 (2000) 959-961
38. Balletshofer B., Rittig K., Enderle M., Volk A., Maerker E., Jacob S., Matthaei S., Rett K., and Häring H. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with Type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
39. Monti L., Barlassina C., Citterio L., Galluccio E., Berzuini C., Setola E., Valsecchi G., Lucotti P., Pozza G., Bernardinelli L., and Piatti P. Endothelial nitric oxide synthase polymorphisms are associated with Type 2 diabetes and the insulin resistance syndrome. Diabetes 52 (2003) 1270-1275
40. Petersen K., Dufour S., Befroy D., Garcia R., and Shulman G. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N Engl J Med 350 (2004) 664-671